Leying Chen

Title: Leying Chen: Innovator in Tumor Therapy

Introduction

Leying Chen is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the area of tumor therapy. With a total of 2 patents, his work focuses on innovative methods to improve patient outcomes in cancer treatment.

Latest Patents

Leying Chen's latest patents include a method for preventing or treating side effects of tumor therapy. This application relates to the use of a nitric oxide releasing agent in the preparation of a medicament aimed at preventing or treating diseases associated with the administration of a VEGFR inhibitor and/or VEGF inhibitor. The method involves administering a therapeutically effective amount of the nitric oxide releasing agent to a subject in need. Another notable patent is for a method to prevent or treat diseases associated with the inhibition of EGFR. This application provides a use of a nitric oxide releasing agent in preparing a medicament for preventing or treating EGFR inhibition-associated epithelial diseases in a subject. It also includes a pharmaceutical composition or kit comprising an EGFR inhibitor and a nitric oxide releasing agent.

Career Highlights

Leying Chen is currently associated with Onquality Pharmaceuticals China Ltd., where he continues to advance his research and development efforts. His work is pivotal in addressing critical challenges in cancer therapy.

Collaborations

Some of his notable coworkers include Shiyi Zhang and Zhaoyu Wu, who contribute to the innovative environment at Onquality Pharmaceuticals.

Conclusion

Leying Chen's contributions to the field of tumor therapy through his innovative patents highlight his commitment to improving cancer treatment. His work exemplifies the importance of research and collaboration in advancing medical science.